Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know

Core Viewpoint - Tenet Healthcare (THC) has shown strong stock performance recently, with a +7.2% return over the past month, outperforming the S&P 500 composite's +0.3% and the Zacks Medical - Hospital industry's +18.7% [1] Earnings Estimates Revisions - Tenet is expected to post earnings of $2.33 per share for the current quarter, reflecting a year-over-year increase of +61.8%, with a consensus estimate change of +44.2% over the last 30 days [4] - The consensus earnings estimate for the current fiscal year is $10.70, indicating a year-over-year change of +53.3%, with a +20.6% change in estimates over the last 30 days [4] - For the next fiscal year, the consensus earnings estimate is $10.96, showing a +2.4% change from the previous year, with a +24.4% change in estimates over the past month [5] Stock Rating and Valuation - Tenet has received a Zacks Rank 1 (Strong Buy), indicating a strong potential for near-term price performance based on earnings estimate revisions [6] - The Zacks Value Style Score grades Tenet as A, suggesting it is trading at a discount compared to its peers [14] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $5.05 billion, indicating a year-over-year change of -0.4%, while estimates for the current and next fiscal years are $20.84 billion (+1.4%) and $21.64 billion (+3.8%), respectively [8] Last Reported Results - In the last reported quarter, Tenet generated revenues of $5.1 billion, a year-over-year increase of +0.4%, and an EPS of $2.31 compared to $1.44 a year ago [9] - The reported revenues exceeded the Zacks Consensus Estimate of $4.98 billion by +2.49%, and the EPS surprise was +22.22% [10]